FDA’s Regulation of the Anti-Mullerian Hormone Test System
Gain in-depth insights into the FDA’s classification of the anti-mullerian hormone test system as a Class II device with special controls. This course delves into the regulatory framework that ensures safety and effectiveness, facilitating patient access to innovative medical devices. Discover how special controls mitigate risks and enhance device reliability, ultimately supporting fertility assessment processes.
In this course you will learn the following:
* Understand the classification process and criteria for the anti-mullerian hormone test system.
* Identify the special controls required for compliance.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.